Omega Fund Management as of Sept. 30, 2019
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 14 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gossamer Bio (GOSS) | 34.0 | $110M | 6.6M | 16.79 | |
| Replimune Group (REPL) | 21.8 | $71M | 5.1M | 13.85 | |
| Morphic Hldg (MORF) | 16.6 | $54M | 3.0M | 18.11 | |
| Translate Bio | 7.5 | $24M | 2.4M | 9.91 | |
| Immunic (IMUX) | 4.2 | $14M | 1.4M | 10.00 | |
| Paratek Pharmaceuticals | 3.5 | $11M | 2.6M | 4.32 | |
| Obseva Sa | 2.6 | $8.3M | 999k | 8.33 | |
| Prevail Therapeutics Ord | 2.5 | $8.2M | 669k | 12.28 | |
| Essa Pharma (EPIX) | 1.8 | $5.8M | 1.7M | 3.37 | |
| Trevi Therapeutics (TRVI) | 1.8 | $5.7M | 1.3M | 4.50 | |
| Fibrogen (FGEN) | 1.5 | $4.8M | 131k | 36.98 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.0 | $3.3M | 1.6M | 2.00 | |
| Pieris Pharmaceuticals | 0.8 | $2.6M | 751k | 3.41 | |
| Jounce Therapeutics | 0.5 | $1.8M | 530k | 3.33 |
